Skip to main content

Funding round · 2026-10-28 · Healthcare

Samplix raises $27.0M

58
AI Score
Amount
$27.0M
Round
Undisclosed
Lead
WLanholding GmbH
HQ
Birkerød, DK
Why it matters: The funding breakdown and the incoming board member from Evotec show how a single-cell screening platform is being positioned for AI-driven drug discovery data needs.

Samplix, a Danish biotech company, announced a €25 million first close of its financing round.

Participants:
—

Deal Dossier PRO

Pro feature
Deal Dossier for Samplix

Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.

Generate dossier — Pro
Already Pro? Sign in · See plans

Figures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).

Recent Healthcare rounds

Browse all deals in the funding database →

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing